Centre National de la Recherche Scientifique - CNRS
About Centre National de la Recherche Scientifique
The Centre National de la Recherche Scientifique (National Center for Scientific Research) is a government-funded research organization, under the administrative authority of France's Ministry of Research. Founded in 1939 by governmental decree, CNRS has the following missions: * To evaluate and carry out all research capable of advancing knowledge and bringing social, cultural, and economic benefits for society * To contribute to the application and promotion of research results * To develop scientific information * To support research training * To participate in the analysis of the national and international scientific climate and its potential for evolution in order to develop a national policy CNRS research units are located throughout France, and employ a large body of tenured researchers, engineers, and support staff. Laboratories are all on renewable four-year contracts, with bi-annual evaluation. There are two types of labs: * CNRS intramural labs: fully funded and managed by CNRS (called UPR, or unités propres de recherche, in French) * Joint labs: partnered with universities, other research organizations, or industry (called UMR, or unités mixtes de recherche, in French)
- Industry : Other
News about Centre National de la Recherche Scientifique
Here you will find Centre National de la Recherche Scientifique - CNRS
Last viewed contents
MorphoSys Announces Second Clinical Milestone in Therapeutic Antibody Program - First HuCAL-based Antibody to Enter Clinical Trial in Second Indication
Viruses on the run - ETH Zurich Professor Ari Helenius awarded Benoist Prize
New approach in the treatment of non-alcoholic fatty liver disease - Resistant starch, such as that found in green bananas, may play an important role in treatment of non-alcoholic fatty liver disease in the future
New model could revolutionise the treatment of autoimmune disease as well as vaccine development - Paradigm shift in immunology: 'Adaptive Tolerance' balances autoimmune reaction
Successful Outcome from European Clinical Pharmacokinetic Study Comparing SUBA-Itraconazole with Sporanox - HalcyGen to begin Marketing Authorisation Application for Regulators in Europe
Evotec Receives a Milestone Payment as Part of its Discovery Alliance with Boehringer Ingelheim
UF study strengthens concerns about long-term use of certain painkillers
Scientists at Almac and Queen’s University Belfast discover novel approach to treat cancer patients.
Restoring chemotherapy sensitivity by boosting microRNA levels
Bayer and Onyx Initiate Phase III Trial of Nexavar in Patients with Non-Responsive Thyroid Cancer
